Compare Edwards Lifesciences Corporation Common Stock (EW) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Lennar Corporation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.9 (market cap $48.56B), while Lennar Corporation trades at $76.09 (market cap $18.44B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 2.6× Lennar Corporation's market cap, and Lennar Corporation pays a 2.58% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | LEN | |
|---|---|---|
Market Cap | $48.56B | $18.44B |
Volume | 6,520,488 | 6,012,214 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $133.13 |
52-Week Low | $72.65 | $74.44 |
Enterprise Value | $45.01B | $22.86B |
Typical Hold Time | — | 67 Days |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lennar Corporation (LEN) trades at $76.13, down 1.65% on the day, with a bearish technical outlook despite appearing fundamentally undervalued with a P/E of 14.7 and P/B of 0.86. Recent earnings have missed expectations for three consecutive quarters, with Q3 2026 results pending. Revenue declined to $34.19 billion in 2025 with net income falling to $2.08 billion, though Berkshire Hathaway has significantly increased its stake, now owning over 11% of the homebuilder.
The stock presents a value opportunity given its below-book valuation and strong institutional backing, but faces headwinds from rising mortgage rates, weak housing sentiment, and recent allegations regarding sales practices. Analyst consensus is mixed with a $77.38 price target slightly above current levels, though technical indicators suggest near-term pressure with support at $74-75.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
